QA Testing

download/print PDF version
reload without photo
PharmLabs San Diego Certificate of Analysis
Sample CBD Therapy RSO
Delta9 THC 125.20% Total THC (THC + THCa) 125.20%
Logo_coa
Sample ID  SD171219-002 (29017) Matrix   Concentrate (Inhalable Cannabis Good)
Tested for  Urban Bootleggers
Sampled   - Received   Dec 19, 2017 Reported   Dec 20, 2017
Analyses executed   CAN+

CAN+ - Cannabinoids

Analyzed Dec 20, 2017  |  Instrument HPLC-VWD  | Method SOP-001
The expanded Uncertainty of the Cannabinoid analysis is approximately ±7.806% at the 95% Confidence Level
Analyte   LOD
mg/g
LOQ
mg/g
Result
%
Result
mg/g
Cannabidivarin (CBDV)   0.039 0.16 NT NT
Cannabidiolic Acid (CBDA)   0.001 0.16 NT NT
Cannabigerol Acid (CBGA)   0.001 0.16 NT NT
Cannabigerol (CBG)   0.001 0.16 NT NT
Cannabidiol (CBD)   0.001 0.16 30.45 304.50
Tetrahydrocannabivarin (THCV)   0.001 0.16 NT NT
Cannabinol (CBN)   0.001 0.16 0.06 0.65
Tetrahydrocannabinol (Δ9-THC)   0.003 0.16 12.52 125.20
Δ8-tetrahydrocannabinol (Δ8-THC)   0.004 0.16 NT NT
Cannabicyclol (CBL)   0.002 0.16 NT NT
Cannabichromene (CBC)   0.002 0.16 NT NT
Tetrahydrocannabinolic Acid (THCA)   0.001 0.16 NT NT
Total THC ( THCa * 0.877 + Δ9THC )       12.52 125.20
Total Cannabinoids Analyzed       43.04 430.35